Charalambos Andreadis
- Cancer Research top 2%
- Oncology top 2%
- CAR-T cell therapy research 35
- Viral-associated cancers and disorders 9
-
- Lymphoma Diagnosis and Treatment 48
- Hematology top 5%
- Acute Myeloid Leukemia Research 16
- Molecular Biology top 5%
- Histone Deacetylase Inhibitors Research 6
-
- Chronic Lymphocytic Leukemia Research 18
-
- Acute Lymphoblastic Leukemia research 10
-
- Frailty in Older Adults 8
- Co-authors
- Craig B. ThompsonGeorgia HatzivassiliouFangping ZhaoDaniel E. BauerDashyant DhanakAnthony N. ShawSunil R. HingoraniDavid A. Tuveson
- Partner nations
- United StatesGreeceGermany
In The Last Decade
Charalambos Andreadis
122 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Cancer Research 1.0k
- Oncology 1.4k
- Pathology and Forensic Medicine 650
- Hematology 255
- Molecular Biology 1.5k
Countries citing papers authored by Charalambos Andreadis
This map shows the geographic impact of Charalambos Andreadis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charalambos Andreadis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charalambos Andreadis more than expected).
Fields of papers citing papers by Charalambos Andreadis
This network shows the impact of papers produced by Charalambos Andreadis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charalambos Andreadis. The network helps show where Charalambos Andreadis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charalambos Andreadis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2021 | 4 | |
| 4 | 2020 | 10 | |
| 5 | 2020 | 7 | |
| 6 | 2020 | 4 | |
| 7 | 2019 | 33 | |
| 8 | 2019 | 16 | |
| 9 | 2019 | 89 | |
| 10 | 2019 | 16 | |
| 11 | 2019 | 2 | |
| 12 | 2018 | 5 | |
| 13 | 2015 | 4 | |
| 14 | 2014 | 10 | |
| 15 | 2011 | 2 | |
| 16 | 2010 | 2 | |
| 17 | 2010 | 6 | |
| 18 | 2008 | 29 | |
| 19 | 2008 | 9 | |
| 20 | 2006 | 52 |
About Charalambos Andreadis
Charalambos Andreadis is a scholar working on Oncology, Pathology and Forensic Medicine and Hematology, having authored 127 papers that have together received 3.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (48 papers), CAR-T cell therapy research (35 papers), Chronic Lymphocytic Leukemia Research (18 papers), Acute Myeloid Leukemia Research (16 papers), Acute Lymphoblastic Leukemia research (10 papers), Viral-associated cancers and disorders (9 papers), Frailty in Older Adults (8 papers) and Histone Deacetylase Inhibitors Research (6 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (1.4k citations) and Pathology and Forensic Medicine (650 citations). Charalambos Andreadis has collaborated with scholars based in United States, Greece and Germany. Frequent co-authors include Craig B. Thompson, Georgia Hatzivassiliou, Fangping Zhao, Daniel E. Bauer, Dashyant Dhanak, Anthony N. Shaw, Sunil R. Hingorani, David A. Tuveson, Stephen J. Schuster and Jeremy S. Abramson. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.